Fundz

ReAlta Life Sciences Closes $14 Million Series A2 Financing to Support Transition into a Clinical Organization

PRIVATEApr 21, 2020

Amount Raised

$14 Million

Round Type

Series A

NorfolkBiotechnologyHealthcareHealth Care

Description

ReAlta Life Sciences, Inc., today announced that it has successfully closed an oversubscribed Series A2 financing of $14 million, bringing the total Series A financing to $26 million. The financings were led by Children’s Research Holdings and Marathon Pharma, as well as additional undisclosed investors. ReAlta Life Sciences is a biotech company dedicated to harnessing the power of the immune system through its PIC1 technology platform to address life-threatening medical needs.

Quick answer

ReAlta Life Sciences raised $14 Million in a Series A round, dated April 21, 2020. ReAlta Life Sciences is based in Norfolk, Virginia, United States.

How much did ReAlta Life Sciences raise?
ReAlta Life Sciences raised $14 Million in a Series A round on April 21, 2020.
What does ReAlta Life Sciences do?
ReAlta Life Sciences is a clinical-stage biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute inflammatory and rare diseases.
Where is ReAlta Life Sciences based and how big is it?
ReAlta Life Sciences is based in Norfolk, Virginia, United States. Fundz records about 31 employees.
Who are the decision-makers at ReAlta Life Sciences?
Fundz holds 1 contact at ReAlta Life Sciences, including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as ReAlta Life Sciences that raised within 45 days of this round, from Fundz verified event records.

  • INVO Fertility, Inc. raised $2.1M (Seed) on May 28, 2020.
  • Greenbrook TMS raised $4.3M (Seed) on May 27, 2020.
  • CervoMed raised $750K (Seed) on May 27, 2020.
  • Axial Therapeutics raised $7.8M on May 22, 2020.
  • Novabay raised $1K on May 22, 2020.
  • Check-Cap Ltd raised $3M (Seed) on May 21, 2020.

Who to call at ReAlta Life Sciences, and when

A new round usually means ReAlta Life Sciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ReAlta Life Sciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ReAlta Life Sciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ReAlta Life Sciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ReAlta Life Sciences

Location

5665 LOWERY ROAD, SUITE 100

Norfolk, Virginia, United States

About

ReAlta Life Sciences is a clinical-stage biotech company dedicated to saving lives by rebalancing the inflammatory response to address life threatening acute inflammatory and rare diseases. ReAlta’s EPICC peptides are based on research into the human astrovirus, HAstV-1, which causes a non-inflammatory, self-limiting gastroenteritis unique among viruses by inhibiting components of the innate immune system. ReAlta’s therapeutic peptides leverage these virus-derived mechanisms to rebalance complement and inflammatory processes in the body. The company’s pipeline is led by RLS-0071, which has received IND clearance by the U.S. Food and Drug Administration (FDA) for the treatment of acute exacerbations of chronic obstructive pulmonary disease and acute graft-versus-host disease, and IND clearance, Orphan Drug Designation, and Fast Track Designation by the FDA, and Orphan Drug Designation by the European Medicines Agency, for the treatment of hypoxic-ischemic encephalopathy (HIE). The company launched in 2018, and is located in Norfolk, Virginia.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ReAlta Life Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNeel K., Executive OfficerSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ReAlta Life Sciences's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

ReAlta Life Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.